In September of 2011, Angela was diagnosed with Stage IV brain cancer. Since then, she has undergone 13 hours of surgery, 42 oral chemotherapy treatments, and 30 radiation therapies; more than any one individual or family should ever have to endure, especially since she is a 10-year breast cancer survivor. She was being treated with Avastin up until June 2013 when she suffered three strokes and had to be taken off the drug due to its stroke risk.
During 2013, Dana-Farber completed genetic mapping of Angela's tumor and was able to identify a genetic mutation. At the same time, a new revolutionary drug was FDA approved for human trial that specifically targets her mutation. Dana-Farber recommended Angela to the pharmaceutical company and was accepted. She began this new therapy in late August and there has been no growth of the tumor to date. The cost of this trial is being covered by Dana-Farber through monies received through our fundraising efforts and other funding.
Angela & Pat Palmer have personally pledged $100,000 to create the Angela and Patrick Palmer Research Fund at the Dana-Farber Cancer Institute. The purpose of this fund is to support the research of the Neuro-Oncology Department and one day find a cure for this dreaded disease. The goal is to raise $3 million over five years with the hope of significantly impacting this difficult disease with improved outcomes for all patients.
Angela's Fund is a 501(c)3 and all donations are tax deductible.